"CABERGLOW 0.50: Relief from Hyperprolactinemia Symptoms"

CABERGLOW 0.50 

Cabergoline IP(0.5mg)

Introduction to Cabergoline

CABERGLOW 0.50  is a combination Cabergoline is a potent dopamine receptor agonist primarily used to treat hyperprolactinemia, a condition characterized by elevated levels of the hormone prolactin. At a dosage of 0.5mg, Cabergoline effectively reduces prolactin levels, helping to restore normal reproductive function and alleviate symptoms associated with this condition.

How Cabergoline Works

Cabergoline works by stimulating dopamine receptors in the pituitary gland, which inhibits the secretion of prolactin. By reducing prolactin levels, Cabergoline helps to normalize menstrual cycles, improve fertility, and prevent symptoms such as galactorrhea (unexpected milk production) and gynecomastia (breast enlargement in men).

Benefits of Cabergoline IP (0.5mg)

• Effective Prolactin Reduction: Cabergoline significantly lowers prolactin levels, restoring hormonal balance.
• Improved Reproductive Health: Helps to regulate menstrual cycles and enhance fertility in women.
• Symptom Relief: Alleviates symptoms such as galactorrhea and gynecomastia, improving quality of life.
• Convenient Dosage: The 0.5mg dosage is effective and easy to administer, typically requiring only a few doses per week.

Indications

Cabergoline IP (0.5mg) is indicated for:

• Treatment of hyperprolactinemia.
• Management of prolactin-secreting pituitary adenomas.
• Improvement of symptoms related to elevated prolactin levels.

Dosage and Administration

The usual starting dosage is 0.25mg to 0.5mg taken twice a week. The dosage may be adjusted based on the patient's response and prolactin levels. It is important to follow the healthcare provider’s instructions and not to exceed the recommended dosage.

Side Effects

Common side effects of Cabergoline include nausea, headache, dizziness, and fatigue. These side effects are generally mild and transient. Patients should report any severe or persistent side effects to their healthcare provider.

Conclusion

Cabergoline IP (0.5mg) is an effective treatment for hyperprolactinemia, offering significant benefits in prolactin reduction and symptom relief. By incorporating Cabergoline into their treatment regimen, patients can achieve better reproductive health and improved quality of life.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

   BUY NOW